(QMAR) FT Cboe Vest Growth-100 - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • • Defined Outcome
QMAR: Options, Stocks
The FT Cboe Vest Growth-100 Buffer ETF - March (QMAR) is designed to provide investors with exposure to the performance of the Invesco QQQ Trust, Series 1 (QQQ), while incorporating a buffer against losses. Under normal market conditions, the fund allocates substantially all of its assets to FLEX Options that reference the Underlying ETF. These FLEX Options are exchange-traded, customizable contracts that allow for tailored terms such as strike prices, styles, and expiration dates, offering flexibility in risk management. As a non-diversified fund, QMAR may concentrate its investments in a limited number of securities, which can increase volatility but also allows for targeted exposure to the Nasdaq-100 index through the QQQ ETF.
QMAR is listed on the BATS exchange and falls under the Defined Outcome ETF category, emphasizing its focus on delivering specific risk-return profiles. With an AUM of $450.37M, the fund has attracted significant investor interest, indicating its liquidity and appeal in the market. The funds structure is designed to balance growth potential with downside protection, making it a unique offering in the ETF space.
3-Month Forecast: Based on the provided data, heres a concise 3-month outlook for QMAR: - Price Movement: The funds price is expected to fluctuate between $29.20 and $31.80, influenced by the SMA20 and SMA50 levels. The relatively low ATR of 0.25 suggests moderate volatility, with potential price targets at $30.50 and $31.00. - Technical Indicators: The SMA20 and SMA50 are currently above the SMA200, indicating a bullish trend. This could support a positive outlook, with potential resistance at $31.00 and support at $29.50. - Volume and Liquidity: With an average volume of 22,483 shares over 20 days, QMAR offers moderate liquidity. The significant AUM of $450.37M underscores its stability and investor confidence, which may attract further inflows and support price stability. - Market Sentiment: The funds performance is closely tied to the Nasdaq-100 index. A strong earnings season or positive macroeconomic data could boost the index, benefiting QMAR. Conversely, any downturn in tech stocks could impact the fund negatively. Overall, QMAR is expected to maintain its current trajectory, with potential for modest growth, supported by its structured approach and the underlying strength of the QQQ ETF.Additional Sources for QMAR ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
QMAR ETF Overview
Market Cap in USD | 431m |
Category | Defined Outcome |
TER | 0.90% |
IPO / Inception | 2021-03-19 |
QMAR ETF Ratings
Growth 5y | 61.9% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | -0.91 |
Analysts | - |
Fair Price Momentum | 26.79 USD |
Fair Price DCF | - |
QMAR Dividends
No Dividends PaidQMAR Growth Ratios
Growth Correlation 3m | 3.1% |
Growth Correlation 12m | 91.8% |
Growth Correlation 5y | 78.8% |
CAGR 5y | 8.50% |
CAGR/Max DD 5y | 0.43 |
Sharpe Ratio 12m | 1.36 |
Alpha | -0.09 |
Beta | 0.78 |
Volatility | 30.40% |
Current Volume | 17k |
Average Volume 20d | 16.1k |
As of March 14, 2025, the stock is trading at USD 27.95 with a total of 17,000 shares traded.
Over the past week, the price has changed by -4.05%, over one month by -9.19%, over three months by -7.19% and over the past year by +7.26%.
Yes. Based on ValueRay Analyses, FT Cboe Vest Growth-100 (BATS:QMAR) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.92 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of QMAR as of March 2025 is 26.79. This means that QMAR is currently overvalued and has a potential downside of -4.15%.
FT Cboe Vest Growth-100 has no consensus analysts rating.
According to ValueRays Forecast Model, QMAR FT Cboe Vest Growth-100 will be worth about 29.6 in March 2026. The stock is currently trading at 27.95. This means that the stock has a potential upside of +5.94%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 29.6 | 5.9% |